NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nextkidney

Nextkidney

Private
BussumHealthcare & Life Scienceshttps://nextkidney.com/

Last Round

Grant

Jul 29, 2025

Total Funding Raised

$12.72M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Nextkidney is a therapeutic devices company developing a portable home hemodialysis device intended to promote homecare.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

home hemodialysisportable hemodialysishemodialysis deviceend-stage renal diseaseESRDsorbent technologymedical deviceartificial kidneymedtechkidney failure treatmentdialysis machinerenal caredialysis consumableshardware and consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nextkidney Comparables

Compare Nextkidney with similar companies based on industry and business-model similarity.

Nextkidney comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivance
84%
Physidia
84%
Diality
81%

Nextkidney Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 29, 2025
Series BFeb 16, 2023
VC RoundJul 2, 2021

Key People

Founding team and executive leadership

Christian Bluechel

Chief Technology Officer

Executive Team

John Stooker

CFO COO, Chief Financial Officer

Executive Team

Nextkidney Investors

Notable investors and investment history

Nextkidney investors
InvestorRounds
Generous MindsSeries B
European Innovation Council FundGrant
MACSFSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 11, 19% of headcount.

  • Feb 16, 2026

    Grew 22% QoQ, from 41 to 50 employees.

Nextkidney Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nextkidney Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nextkidney's valuation, stock price, and market status.

Firmographic Details

HeadquartersBussum
Employee Range57
Year Founded2019
Last FundingJul 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.